Skip to main content

The Role of MIF in Parasitic Infections

  • Chapter
  • First Online:
MIF Family Cytokines in Innate Immunity and Homeostasis

Abstract

Macrophage migration inhibitory factor (MIF) is a pleiotropic molecule with extensive reach and numerous important roles in shaping the immune response to a large variety of infections and inflammatory diseases. MIF was first identified as a factor capable of preventing random macrophage migration in vitro in 1966 (Proc Natl Acad Sci U S A 56(1):72–77, 1966; Science 153(3731):80–82, 1966). Subsequent efforts to characterize the function of MIF have shown that the roles of this molecule extend far beyond the purview of macrophage migration and into antigen-specific responses (Cell Immunol 1:133–145, 1970) macrophage activation and survival (Proc Natl Acad Sci U S A 99(1):345–350, 2002), modulation of glucocorticoid activity to promote inflammation (Ann N Y Acad Sci 210–220, 1999; Nature 377(6544):68–71, 1995), T cell activation (Proc Natl Acad Sci U S A 93(15):7849–7854, 1996), and macrophage phagocytosis (Immunology 92(1):131–137, 1997). MIF also is involved in the coordination between the innate and adaptive immune response. Due to the sheer number of functions performed by MIF during the immune response, its role during parasitic infections has come under increased scrutiny. Interestingly, MIF has been found to be a critical mediator of immunity against a broad range of parasite infections. Here we summarize the findings relevant to the role of MIF during parasitic infections.

†Cesar Terrazas and James C. Stock are equal contributors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Murray CJL et al (2014) Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden Of Disease Study 2013. Lancet 384(9947):1005–1070. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=4202387&Tool=Pmcentrez&Rendertype=Abstract

    Article  PubMed  PubMed Central  Google Scholar 

  2. Baer K et al (2007) Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog 3(11):1651–1668

    Article  CAS  Google Scholar 

  3. Frevert U et al (2005) Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol 3(6):1034–1046

    Article  CAS  Google Scholar 

  4. Vaughan AM, Aly ASI, Kappe SHI (2008) Malaria parasite pre-erythrocytic stage infection: gliding and hiding. Cell Host Microbe 4:209–218

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Baird JK et al (1998) Age-dependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. J Infect Dis 178:592–595

    Article  CAS  PubMed  Google Scholar 

  6. Mshana RN et al (1991) Cytokines in the pathogenesis of malaria: levels of IL-I beta, IL-4, IL-6, TNF-alpha and IFN-gamma in plasma of healthy individuals and malaria patients in a holoendemic area. J Clin Lab Immunol 34:131–139. Http://Ovidsp.Ovid.Com/Ovidweb.Cgi?T=Js&Csc=Y&News=N&Page=Fulltext&D=Med3&An=1667945; Http://Digitaal.Uba.Uva.Nl:9003/Uva-Linker?Sid=Ovid:Medline&Id=Pmid:1667945&Id=Doi:&Issn=0141-2760&Isbn=&Volume=34&Issue=3&Spage=131&Pages=131-9&Date=1991&Title=Journal+O

  7. López C et al (2010) Mechanisms of genetically-based resistance to malaria. Gene 467(1–2):1–12. Http://Dx.Doi.Org/10.1016/J.Gene2010.07.008

    Article  PubMed  Google Scholar 

  8. Griffin JT et al (2015) Gradual acquisition of immunity to severe malaria with increasing exposure. Proc R Soc B Biol Sci 282:20142657. Http://Rspb.Royalsocietypublishing.Org/Content/282/1801/20142657

    Article  Google Scholar 

  9. Bastos KRB et al (2002) Impaired macrophage responses may contribute to exacerbation of blood-stage Plasmodium chabaudi chabaudi malaria in interleukin-12-deficient mice. J Interferon Cytokine Res 22(12):1191–1199. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/12581492

    Article  CAS  PubMed  Google Scholar 

  10. Franklin BS et al (2009) Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc Natl Acad Sci U S A 106(14):5789–5794. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=2657593&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shear HL et al (1989) Role of IFN-gamma in lethal and nonlethal malaria in susceptible and resistant murine hosts. J Immunol 143(6):2038–2044

    CAS  PubMed  Google Scholar 

  12. Su Z, Stevenson MM (2000) Central role of endogenous gamma interferon in protective immunity against blood-stage plasmodium chabaudi as infection. Infect Immun 68(8):4399–4406. Http://Iai.Asm.Org/Content/68/8/4399\N; http://Iai.Asm.Org/Content/68/8/4399.Full.Pdf\N; http://Iai.Asm.Org/Content/68/8/4399.Short

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Jacobs P, Radzioch D, Stevenson MM (1996) A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect Immun 64:535–541

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Kurtzhals JA et al (1998) Low plasma concentrations of interleukin-10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351:1768–1772

    Article  CAS  PubMed  Google Scholar 

  15. Erunkulu OA et al (1992) Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Clin Exp Immunol 89(2):296–300. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=1554452&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Artavanis-Tsakonas K, Tongren JE, Riley EM (2003) The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol 133(2):145–152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Riley EM et al (1991) Immune-response to soluble exoantigens of Plasmodium falciparum may contribute to both pathogenesis and protection in clinical malaria—evidence from a longitudinal, prospective-study of semi-immune African children. Eur J Immunol 21(4):1019–1025. <Go To Isi>://A1991fj28400023

    Google Scholar 

  18. Calandra T et al (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179(6):1895–1902

    Article  CAS  PubMed  Google Scholar 

  19. Mitchell RA et al (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting P53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A 99(1):345–350

    Article  CAS  PubMed  Google Scholar 

  20. Murakami H et al (2002) Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis. Clin Exp Immunol 128(3):504–510. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=1906246&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Onodera S et al (1997) Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 92(1):131–137

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bacher M et al (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 93(15):7849–7854

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Scragg IG et al (1999) Early cytokine induction by Plasmodium falciparum is not a classical endotoxin-like process. Eur J Immunol 29:2636–2644

    Article  CAS  PubMed  Google Scholar 

  24. Bernhagen J et al (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365(6448):756–759

    Article  CAS  PubMed  Google Scholar 

  25. Bozza M et al (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189(2):341–346

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Awandare GA et al (2006) Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria. Clin Immunol 119(2):219–225. Http://Www.Ncbi.Nlm.Nih.Gov/Entrez/Query.Fcgi?Cmd=Retrieve&Db=Pubmed&Dopt=Citation&List_Uids=16461006\N; http://Www.Sciencedirect.Com/Science?_Ob=Mimg&_Imagekey=B6wcj-4j6wp83-1-5&_Cdi=6740&_User=1535037&_Orig=Search&_Coverdate=05/31/2006&_Sk=998809997&View=

  27. Jha AN et al (2013) Variations in ncRNA gene LOC284889 and MIF-794CATT repeats are associated with malaria susceptibility in indian populations. Malar J 12(1):345. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=3849407&Tool=Pmcentrez&Rendertype=Abstract

    Article  PubMed  PubMed Central  Google Scholar 

  28. Awandare GA et al (2009) MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia. J Infect Dis 200(4):629–637. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=3607439&Tool=Pmcentrez&Rendertype=Abstract

  29. Awandare GA et al (2007a) Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria. Am J Trop Med Hyg 76(6):1033–1036. Http://Www.Ncbi.Nlm.Nih.Gov/Entrez/Query.Fcgi?Cmd=Retrieve&Db=Pubmed&Dopt=Citation&List_Uids=17556607

  30. Awandare GA et al (2007b) Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect Immun 75(1):201–210

    Article  CAS  PubMed  Google Scholar 

  31. De Mast Q et al (2008) A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria. Parasite Immunol 30(3):133–138. Http://Www.Ncbi.Nlm.Nih.Gov/Entrez/Query.Fcgi?Cmd=Retrieve&Db=Pubmed&Dopt=Citation&List_Uids=18179626

    Article  CAS  PubMed  Google Scholar 

  32. Jain V et al (2009) Macrophage migration inhibitory factor is associated with mortality in cerebral malaria patients in India. BMC Res Notes 2:36. Http://Www.Ncbi.Nlm.Nih.Gov/Entrez/Query.Fcgi?Cmd=Retrieve&Db=Pubmed&Dopt=Citation&List_Uids=19284533\N; http://Www.Biomedcentral.Com/Content/Pdf/1756-0500-2-36.Pdf

    Article  PubMed  PubMed Central  Google Scholar 

  33. Martiney JA et al (2000) Macrophage migration inhibitory factor release by macrophages after ingestion of plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect Immun 68(4):2259–2267. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=97412&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Mcdevitt MA et al (2006) A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J Exp Med 203(5):1185–1196. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=2121202&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Cordery DV et al (2007) Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue. J Infect Dis 195(6):905–912. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/17299722

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Dobson SE et al (2009) The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei. Protein Sci 18(12):2578–2591. <Go To Isi>://000272757200015

    Google Scholar 

  37. Augustijn KD et al (2007) Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor. Infect Immun 75(3):1116–1128

    Article  CAS  PubMed  Google Scholar 

  38. Miller JL et al (2012) Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development. Infect Immun 80:1399–1407

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Zhang Y et al (2012) Macrophage migration inhibitory factor homolog from Plasmodium yoelii modulates monocyte recruitment and activation in spleen during infection. Parasitol Res 110(5):1755–1763. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/22015474

    Article  PubMed  Google Scholar 

  40. Shao D et al (2008) Detection of Plasmodium falciparum derived macrophage migration inhibitory factor homologue in the sera of malaria patients. Acta Trop 106(1):9–15. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/18262164

    Article  CAS  PubMed  Google Scholar 

  41. Han C et al (2010) Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity. Clin Vaccine Immunol 17(10):1524–1532

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Dubey JP (1998) Advances in the life cycle of Toxoplasma gondii. Int J Parasitol 28(7):1019–1024

    Article  CAS  PubMed  Google Scholar 

  43. Robert-Gangneux F, Dardé M-L (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25(2):264–296. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=3346298&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363(9425):1965–1976

    Article  CAS  PubMed  Google Scholar 

  45. Hill D, Dubey JP (2002) Toxoplasma gondii: transmission, diagnosis, and prevention. Clin Microbiol Infect 8(10):634–640

    Article  CAS  PubMed  Google Scholar 

  46. Rosado JD, Rodriguez-Sosa M (2011) Macrophage migration inhibitory factor (MIF): a key player in protozoan infections. Int J Biol Sci 7(9):1239–1256

    Article  Google Scholar 

  47. Butcher BA, Denkers EY (2002) Mechanism of entry determines the ability of toxoplasma gondii to inhibit macrophage proinflammatory cytokine production. Infect Immun 70(9):5216–5224. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=128277&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Werk R (1985) How does Toxoplasma gondii enter host cells? Rev Infect Dis 7(4):449–457. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/3898305

    Article  CAS  PubMed  Google Scholar 

  49. Khan IA, Matsuura T, Kasper LH (1994) Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun 62(5):1639–1642. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=186373&Tool=Pmcentrez&Rendertype=Abstract

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Yarovinsky F (2014) Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol 14:109–121. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/24457485

    Article  CAS  PubMed  Google Scholar 

  51. Flores M et al (2008) Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii. FASEB J 22(10):3661–3671. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=2537436&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Terrazas CA et al (2010) Toxoplasma gondii: impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection. Exp Parasitol 126(3):348–358. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/20331989

    Article  CAS  PubMed  Google Scholar 

  53. Liesenfeld O (2002) Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis 185(Suppl 1):S96–S101

    Article  PubMed  Google Scholar 

  54. Cavalcanti MG et al (2011) MIF participates in toxoplasma gondii-induced pathology following oral infection. Plos One 6(9):e25259. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=3178626&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. De Oliveira Gomes A et al (2011) Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age. Am J Pathol 178(6):2792–2801. Http://Dx.Doi.Org/10.1016/J.Ajpath.2011.02.005

    Article  PubMed  PubMed Central  Google Scholar 

  56. Barbosa BF et al (2014) Susceptibility to Toxoplasma gondii proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via Erk1/2 phosphorylation and prostaglandin E2 production. Placenta 35(3):152–162. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/24433846

    Article  CAS  PubMed  Google Scholar 

  57. Junqueira C et al (2010) The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond chagas disease. Expert Rev Mol Med 12:e29

    Article  PubMed  Google Scholar 

  58. Parodi C, Padilla AM, Basombrío MA (2009) Protective immunity against Trypanosoma cruzi. Mem Inst Oswaldo Cruz 104:288–294

    Article  PubMed  Google Scholar 

  59. Aliberti JC et al (2001) Modulation of chemokine production and inflammatory responses in interferon-gamma-and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 158(4):1433–1440

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Gutierrez FRS et al (2009) The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 104(Suppl 1):236–245. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/19753479

    Article  CAS  PubMed  Google Scholar 

  61. Silva JS et al (1995) Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 63:4862–4867

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Reyes JL et al (2006) Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. Infect Immun 74(6):3170–3179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Terrazas CA et al (2011) MIF synergizes with Trypanosoma cruzi antigens to promote efficient dendritic cell maturation and IL-12 production via p38 MAPK. Int J Biol Sci 7(9):1298–1310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Cutrullis RA et al (2013) Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with chagas disease. Plos One 8(2):e57181. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=3579792&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Bosschaerts T et al (2009) Understanding the role of monocytic cells in liver inflammation using parasite infection as a model. Immunobiology 214(9–10):737–747. Http://Dx.Doi.Org/10.1016/J.Imbio.2009.06.010

    Article  CAS  PubMed  Google Scholar 

  66. Magez S et al (2004) P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. J Infect Dis 189(3):527–539

    Article  PubMed  Google Scholar 

  67. Stijlemans B et al (2010) Scrutinizing the mechanisms underlying the induction of anemia of inflammation through gpi-mediated modulation of macrophage activation in a model of African trypanosomiasis. Microbes Infect 12(5):389–399. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/20197106

    Article  CAS  PubMed  Google Scholar 

  68. Nishimura K et al (2011) Effect of Trypanosoma brucei brucei on erythropoiesis in infected rats. J Parasitol 97(1):88–93

    Article  CAS  PubMed  Google Scholar 

  69. Stijlemans B et al (2014) MIF contributes to Trypanosoma brucei associated immunopathogenicity development. Plos Pathog 10(9):e1004414. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=4177988&Tool=Pmcentrez&Rendertype=Abstract

    Article  PubMed  PubMed Central  Google Scholar 

  70. Bosschaerts T et al (2010) Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-Γ and MyD88 signaling. PLoS Pathog 6(8):35–36

    Article  Google Scholar 

  71. Peters NC et al (2008) In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321(5891):970–974

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Alexander J, Bryson K (2005) T helper (H)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett 99(1):17–23

    Article  CAS  PubMed  Google Scholar 

  73. Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191–1199

    Article  CAS  PubMed  Google Scholar 

  74. Kaye P, Scott P (2011) Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9(8):604–615

    Article  CAS  PubMed  Google Scholar 

  75. Jüttner S et al (1998) Migration inhibitory factor induces killing of leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-Alpha. J Immunol 161(5):2383–2390. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/9725234

    PubMed  Google Scholar 

  76. Satoskar AR et al (2001) Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous leishmania major infection. Infect Immun 69(2):906–911

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Kar S, Metz C, Mcmahon-Pratt D (2005) Cd4+ T cells play a dominant role in protection against new world leishmaniasis induced by vaccination with the P-4 amastigote antigen. Infect Immun 73(6):3823–3827. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=1111832&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Kozaci DL et al (2005) [Investigation of serum macrophage migration inhibitor factor (MIF) levels in patients with cutaneous leishmaniasis.]. Türkiye Parazitol Der 29(3):145–148. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/17160809.

    Google Scholar 

  79. Santos-Oliveira JR et al (2011) Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis. PLoS Negl Trop Dis 5(7):e1198. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=3134430&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Kamir D et al (2008) A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J Immunol 180(12):8250–8261. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=2668862&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Allen JE, Maizels RM (2011) Diversity and dialogue in immunity to helminths. Nat Rev Immunol 11(6):375–388

    Article  CAS  PubMed  Google Scholar 

  82. Boros DL, Pelley RP, Warren KS (1975) Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J Immunol 114(5):1437–1441. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/804513

    CAS  PubMed  Google Scholar 

  83. Stavitsky AB et al (2003) Blockade of macrophage migration inhibitory factor (MIF) in Schistosoma japonicum-infected mice results in an increased adult worm burden and reduced fecundity. Parasite Immunol 25(7):369–374. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/14521579

    Article  CAS  PubMed  Google Scholar 

  84. Rodríguez-Sosa M et al (2003) Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite taenia crassiceps. Infect Immun 71(3):1247–1254. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=148860&Tool=Pmcentrez&Rendertype=Abstract

    Article  PubMed  PubMed Central  Google Scholar 

  85. Patil S et al (2006) Proinflammatory cytokines in granulomas associated with murine cysticercosis are not the cause of seizures. J Parasitol 92(4):738–741. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/16995390

    Article  CAS  PubMed  Google Scholar 

  86. Baeza Garcia A et al (2010) Involvement of the cytokine MIF in the snail host immune response to the parasite Schistosoma mansoni. PLoS Pathog 6(9):e1001115. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=2944803&Tool=Pmcentrez&Rendertype=Abstract

    Article  PubMed  PubMed Central  Google Scholar 

  87. Pastrana DV et al (1998) Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun 66(12):5955–5963. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=108754&Tool=Pmcentrez&Rendertype=Abstract

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Falcone FH et al (2001) A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection. J Immunol 167(9):5348–5354. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/11673551

    Article  CAS  PubMed  Google Scholar 

  89. Prieto-Lafuente L et al (2009) MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages. J Leukoc Biol 85(5):844–854. Http://Www.Pubmedcentral.Nih.Gov/Articlerender.Fcgi?Artid=2691607&Tool=Pmcentrez&Rendertype=Abstract

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Cho MK, Lee CH, Yu HS (2011) Amelioration of intestinal colitis by macrophage migration inhibitory factor isolated from intestinal parasites through toll-like receptor 2. Parasite Immunol 33(5):265–275. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/21204854

    Article  CAS  PubMed  Google Scholar 

  91. Park SK et al (2009) Macrophage migration inhibitory factor homologs of anisakis simplex suppress Th2 response in allergic airway inflammation model via CD4+CD25+Foxp3+ T cell recruitment. J Immunol 182(11):6907–6914. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/19454687

    Article  CAS  PubMed  Google Scholar 

  92. Park H-K et al (2012) Macrophage migration inhibitory factor isolated from a parasite inhibited Th2 cytokine production in pbmcs of atopic asthma patients. J Asthma 49(1):10–15. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/22149098

    Article  CAS  PubMed  Google Scholar 

  93. Greven D, Leng L, Bucala R (2010) Autoimmune diseases: MIF as a therapeutic target. Expert Opin Ther Targets 14(3):253–264. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/20148714

    Article  CAS  PubMed  Google Scholar 

  94. Tang F et al (2013) A DNA vaccine co-expressing Trichinella spiralis MIF and MCD-1 with murine ubiquitin induces partial protective immunity in mice. J Helminthol 87(1):24–33. Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/22221593

    Article  CAS  PubMed  Google Scholar 

  95. Angeli A et al (1999) Modulation by cytokines of glucocorticoid action. Ann N Y Acad Sci 876:210–220

    Article  CAS  PubMed  Google Scholar 

  96. Bloom BR, Bennett B (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153(3731):80–82

    Article  CAS  PubMed  Google Scholar 

  97. Calandra T et al (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377(6544):68–71

    Article  CAS  PubMed  Google Scholar 

  98. David J (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A 56(1):72–77

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Remold HG et al (1970) Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis. Cell Immunol 1:133–145

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abhay R. Satoskar M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Terrazas, C., Stock, J.C., Kimble, J., Moretti, E., Varikuti, S., Satoskar, A.R. (2017). The Role of MIF in Parasitic Infections. In: Bucala, R., Bernhagen, J. (eds) MIF Family Cytokines in Innate Immunity and Homeostasis. Progress in Inflammation Research. Springer, Cham. https://doi.org/10.1007/978-3-319-52354-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52354-5_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52352-1

  • Online ISBN: 978-3-319-52354-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics